Teruo Inoue
Department of Cardiovascular Medicine
Dokkyo Medical University
Mibu, Tochigi
Japan
Name/email consistency: high
- Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan. Inoue, T., Taguchi, I., Abe, S., Toyoda, S., Sakuma, M., Node, K. J. Clin. Pharm. Ther (2011)
- Sulfatides are associated with neointimal thickening after vascular injury. Inoue, T., Taguchi, I., Abe, S., Li, G., Hu, R., Nakajima, T., Hara, A., Aoyama, T., Kannagi, R., Kyogashima, M., Node, K. Atherosclerosis (2010)
- Remnant-like lipoprotein particles as risk factors for coronary artery disease in elderly patients. Inoue, T., Uchida, T., Kamishirado, H., Takayanagi, K., Hayashi, T., Morooka, S., Saniabadi, A.R., Nakajima, K. Horm. Metab. Res. (2004)
- Cigarette smoking as a risk factor of coronary artery disease and its effects on platelet function. Inoue, T. Tob. Induc. Dis (2004)
- Stent-induced expression and activation of the leukocyte integrin Mac-1 is associated with neointimal thickening and restenosis. Inoue, T., Uchida, T., Yaguchi, I., Sakai, Y., Takayanagi, K., Morooka, S. Circulation (2003)
- Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction. Inoue, T., Yaguchi, I., Mizoguchi, K., Uchida, T., Takayanagi, K., Hayashi, T., Morooka, S., Eguchi, Y. Clin. Cardiol (2003)
- Fluvastatin attenuates nitrate tolerance in patients with ischemic heart disease complicating hypercholesterolemia. Inoue, T., Takayanagi, K., Hayashi, T., Morooka, S. Int. J. Cardiol. (2003)
- Circulating matrix metalloproteinase-1 and -3 in patients with an acute coronary syndrome. Inoue, T., Kato, T., Takayanagi, K., Uchida, T., Yaguchi, I., Kamishirado, H., Morooka, S., Yoshimoto, N. Am. J. Cardiol. (2003)
- Three-dimensional computed tomography showing partial anomalous pulmonary venous connection complicated by the scimitar syndrome. Inoue, T., Ichihara, M., Uchida, T., Sakai, Y., Hayashi, T., Morooka, S. Circulation (2002)
- Lipid-lowering therapy with fluvastatin inhibits oxidative modification of low density lipoprotein and improves vascular endothelial function in hypercholesterolemic patients. Inoue, T., Hayashi, M., Takayanagi, K., Morooka, S. Atherosclerosis (2002)
- A new thrombolytic agent, monteplase, is independent of the plasminogen activator inhibitor in patients with acute myocardial infarction: initial results of the COmbining Monteplase with Angioplasty (COMA) trial. Inoue, T., Yaguchi, I., Takayanagi, K., Hayashi, T., Morooka, S., Eguchi, Y. Am. Heart J. (2002)
- Clinical significance of the antibody against oxidized low-density lipoprotein in acute myocardial infarction. Inoue, T., Yaguchi, I., Uchida, T., Kamishirado, H., Nakahara, S., Hayashi, T., Morooka, S. Cardiology (2002)
- Possible relationship between insulin resistance and remnant-like lipoprotein particles in coronary endothelial dysfunction. Inoue, T., Uchida, T., Kamishirado, H., Sakuma, M., Sakai, Y., Takayanagi, K., Hayashi, T., Morooka, S. Clin. Cardiol (2002)
- Serum prostaglandin D synthase level after coronary angioplasty may predict occurrence of restenosis. Inoue, T., Takayanagi, K., Morooka, S., Uehara, Y., Oda, H., Seiki, K., Nakajima, H., Urade, Y. Thromb. Haemost. (2001)
- Immunological response to oxidized LDL occurs in association with oxidative DNA damage independently of serum LDL concentrations in dyslipidemic patients. Inoue, T., Inoue, K., Maeda, H., Takayanagi, K., Morooka, S. Clin. Chim. Acta (2001)
- Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease. Inoue, T., Uchida, T., Kamishirado, H., Takayanagi, K., Morooka, S. J. Am. Coll. Cardiol. (2001)
- Clinical significance of antibody against oxidized low density lipoprotein in patients with atherosclerotic coronary artery disease. Inoue, T., Uchida, T., Kamishirado, H., Takayanagi, K., Hayashi, T., Morooka, S. J. Am. Coll. Cardiol. (2001)
- Air embolism in the right coronary artery occurring during the left coronary angioplasty using the guiding catheter with a side hole. Inoue, T., Yaguchi, I., Mizoguchi, K., Hoshi, K., Takayanagi, K., Morooka, S., Saito, S. Catheter. Cardiovasc. Interv (2000)
- Cilostazol inhibits the expression of activation-dependent membrane surface glycoprotein on the surface of platelets stimulated in vitro. Inoue, T., Sohma, R., Morooka, S. Thromb. Res. (1999)